Hatao Fumihiko, Yamamoto Maya, Muroi Masashi, Kaminishi Michio, Tanamoto Ken-ichi
Department of Metabolic Care and Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
FEMS Immunol Med Microbiol. 2008 Jul;53(2):260-4. doi: 10.1111/j.1574-695X.2008.00425.x. Epub 2008 May 21.
IRAK-4 plays an essential role in Toll-like receptor (TLR)/IL-1 receptor signaling. However, its signaling and regulation mechanisms have remained elusive. We have reported previously that stimulation of TLR2, TLR4 or TLR9, but not TLR3, leads to downregulation of IRAK-4 protein. Here, we show that expression of MyD88 leads to downregulation of endogenous as well as exogenously expressed IRAK-4 protein in HEK293 cells. Expression of TRIF did not cause IRAK-4 downregulation although it induced NF-kappaB activation. Expression of either a deletion mutant of MyD88 lacking its death domain or MyD88s, neither of which induced NF-kappaB activation, did not lead to IRAK-4 downregulation. MyD88-induced downregulation was observed in an IRAK-4 mutant lacking the kinase domain, but not in another mutant lacking the death domain. These results demonstrate that downregulation of IRAK-4 requires activation of the MyD88-dependent pathway and that the death domains of both MyD88 and IRAK-4 are important for this downregulation.
白细胞介素-1受体相关激酶4(IRAK-4)在Toll样受体(TLR)/白细胞介素-1受体信号传导中起关键作用。然而,其信号传导和调控机制仍不清楚。我们之前报道过,刺激TLR2、TLR4或TLR9(而非TLR3)会导致IRAK-4蛋白表达下调。在此,我们表明髓样分化因子88(MyD88)的表达会导致人胚肾293(HEK293)细胞内源性以及外源性表达的IRAK-4蛋白表达下调。虽然TIR结构域衔接蛋白诱导干扰素β(TRIF)的表达可诱导核因子κB(NF-κB)激活,但不会导致IRAK-4下调。MyD88缺失死亡结构域的缺失突变体或MyD88s(MyD88的一种短异构体)的表达均不会导致IRAK-4下调,二者均不会诱导NF-κB激活。在缺乏激酶结构域的IRAK-4突变体中观察到MyD88诱导的下调,但在另一种缺乏死亡结构域的突变体中未观察到。这些结果表明,IRAK-4的下调需要MyD88依赖途径的激活,并且MyD88和IRAK-4的死亡结构域对于这种下调都很重要。